✦ LIBER ✦

Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma

✍ Scribed by A.K. Kivisaari; M. Kallajoki; R. Ala-aho; J.A. McGrath; J.W. Bauer; R. Königová; M. Medvecz; W. Beckert; R. Grénman; V.-M. Kähäri

Book ID: 108671337
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 873 KB
Volume: 163
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2010.09924.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of Heparin-Binding Epidermal

Expression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Breast Carcinoma

✍ Yasuhiro Ito; Tsutomu Takeda; Shigeki Higashiyama; Shinzaburo Noguchi; Nariaki M 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 122 KB

Proteolytic activation of heparin-bindin

Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells

✍ Naohiko Koshikawa; Hiroto Mizushima; Tomoko Minegishi; Fuyuki Eguchi; Fusanori Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 611 KB

Dual inhibition of epidermal growth fact

Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: Reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma

✍ Chad E. Galer; Christina L. Corey; Zhuoying Wang; Maher N. Younes; Fernando Gome 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

## Abstract ## Background Cutaneous squamous cell carcinoma (CSCC) is the second most common nonmelanoma skin cancer. Most of the approximately 250,000 cases occurring annually in the United States are small, nonaggressive, and cured by excision alone. However, a subset of these tumors which are d

Amino-terminal deletion of heparin-bindi

Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4−127 stimulates cell proliferation but lacks insulin-like activity

✍ Z. Zhou; P. A. Harding 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

Induction of heparin-binding EGF-like gr

Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells

✍ Faye M. Johnson; Babita Saigal; Nicholas J. Donato 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases. Inhibition of BCR-ABL and c-kit accounts for its clinical activity in leukemia and sarcoma, respectively. In this report, we describe other cellular targets for imatinib.

A synthetic matrix metalloproteinase inh

A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops

✍ Pornchai O-Charoenrat; Peter Rhys-Evans; Suzanne Eccles 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB

## Abstract Head and neck squamous cell carcinoma (HNSCC) is characterized by its capacity to invade adjacent tissues and to metastasize locoregionally. Evidence suggests that matrix metalloproteinases (MMPs) may play a causal role in HNSCC progression. While evaluating the role of MMPs in the inva